Morgan Stanley
-
-
-
-
-
-
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Enters into a Non-dilutive Revenue Interest Financing Agreement with HealthCare Royalty for up to $100 Million
-
-
-
-
-
-
-
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
-
-
-
-
-
-
-
Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
-
-
-
-
-
-
-
Rhythm Pharmaceuticals to Present at Morgan Stanley 16th Annual Global Healthcare Conference
-
-
-
-
-
-
-
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
-
211,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

